Camp4 Therapeutics (CAMP) Net Margin (2023 - 2026)
Camp4 Therapeutics (CAMP) posted Net Margin of 944.13% for Q1 2026, up 66.03% sequentially from 2779.02% in Q4 2025, and up 64655.0% YoY from N/an in Q1 2025.
Camp4 Therapeutics (CAMP) Net Margin (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Net Margin for 4 years, with the latest figure at 944.13% in Q1 2026.
- Quarterly Net Margin rose 64655.0% year-over-year to 944.13% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1426.56% (up 264218.0% YoY) and the FY2025 annual result came in at 3616.95%, up 1427860.0% from the prior year.
- Net Margin improved to 944.13% in Q1 2026 per CAMP's latest filing, from 2779.02% in the prior quarter.
- Over five years, Net Margin peaked at 944.13% in Q1 2026 and troughed at 3544.0% in Q3 2023.
- A 4-year average of 1950.5% and a median of 1676.99% in 2024 frame the typical range for Net Margin.
- The sharpest annual moves came in 2025 and 2026: Net Margin plunged 110203 bps in 2025, then soared 64655 bps in 2026.
- Over 4 years, Net Margin stood at 3544.0% in 2023, then soared by 53 bps to 1676.99% in 2024, then plunged by 66 bps to 2779.02% in 2025, then soared by 66 bps to 944.13% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 944.13%, 2779.02%, and 1774.09% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 30.33% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.90% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 30.98% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 12.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -3.12% |
| 10 | Camp4 Therapeutics | 282.48 Mn | 282.48 Mn | - | -845.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -845.87% |
| Mar 31, 2026 | -944.13% |
| Dec 31, 2025 | -2,779.02% |
| Sep 30, 2025 | -1,774.09% |
| Jun 30, 2025 | -1,344.62% |
| Mar 31, 2025 | -1,590.68% |
| Dec 31, 2024 | -1,676.99% |
| Sep 30, 2023 | -3,544.00% |